End of the line looms for Able Laboratories

Another example of the cost of quality, or rather, the non-conformances...

So if you ever hear something along the lines of "yeah, but look at all the money we'll save...it's not like it's gonna bring the company down or anything..."; It's time to stop and wonder...

Troubled generic drug manufacturer Able Laboratories has conceded defeat in its bid to get products back onto the market and elected to sell off the assets of the business.

Able was forced to cease manufacturing and recall all of its products in May after serious questions were raised about quality control data used to obtain approval for products made at its manufacturing facility in New Jersey. The company has been in negotiations with the US Food and Drug Administration (FDA) for a ‘rescue package' that would allow it to start making and selling products again. But these have failed, according to a company statement released yesterday.

link from in-pharmatech.com